Understanding cost of care for patients on renal replacement therapy: Looking beyond fixed tariffs

Nephrology Dialysis Transplantation

Volumn 30, Issue 10, 2015, Pages 1726-1734

  Li, Bernadette ^a   Cairns, John A ^a   Fotheringham, James ^b   Tomson, Charles R ^c   Forsythe, John L ^d   Watson, Christopher ^e   Metcalfe, Wendy ^f   Fogarty, Damian G ^g   Draper, Heather ^h   Oniscu, Gabriel C ^d   Dudley, Christopher ^c   Johnson, Rachel J ⁱ   Roderick, Paul ^j   Leydon, Geraldine ^j   Bradley, J Andrew ^e   Ravanan, Rommel ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Sheffield Kidney Institute   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Scottish Renal Registry   (United Kingdom)

^g ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ NHS BLOOD AND TRANSPLANT   (United Kingdom)

^j UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

comorbidities; established renal failure; hospital costs; regression; renal replacement therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY GRAFT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED KINGDOM; VERY ELDERLY; ECONOMICS; ENGLAND; HOSPITALIZATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; REGISTER; STATISTICS AND NUMERICAL DATA;

AGED; COMORBIDITY; DIABETES MELLITUS; ENGLAND; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; REGISTRIES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 84943421109     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv224     Document Type: Article

References (19)

1. Vanholder R, Davenport A, Hannedouche Tet al. Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol 2012; 23: 1291-1298
2. Sharif A, Baboolal K. Update on dialysis economics in the UK. Perit Dial Int 2011; 31 (Suppl 2): S58-S62
3. Department of Health. Payment by results guidance for 2013-14. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/214902/PbR-Guidance-2013-14.pdf (Accessed 16 July 2014
4. Rao A, Steenkamp R, Caskey F. UK Renal Registry 16th Annual Report: Chapter 5 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012. Nephron Clin Pract 2013; 125: 99-110
5. Grun RP, Constantinovici N, Normand C, et al. Costs of dialysis for elderly people in the UK. Nephrol Dial Transplant 2003; 18: 2122-2127
6. Metcalfe W, Khan IH, Prescott GJ, et al. Hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM 2003; 96: 899-909
7. Roderick P, Nicholson T, Armitage A, et al. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. Health Technol Assess 2005; 9: 1-178
8. Fotheringham J, Fogarty D, Jacques R, et al. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy. Nephron Clin Pract 2012; 120 (Suppl 1): c247-c260
9. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139
10. Department ofHealth.Confirmation of payment by results (PbR) arrangements for 2011-12. http://webarchive.nationalarchives.gov.uk/20130507170152/https: /www.gov.uk/government /publications/confirmation-of-payment-by -resultspbr-arrangements-for-2011-12 (Accessed 21 July 2014 (Accessed 21 July
11. Fagerland MW. t-tests, non-parametric tests, and large studies-a paradox of statistical practice?. BMC Med Res Methodol 2012; 12: 78-84
12. Skovlund E, Fenstad GU. Should we always choose a nonparametric test when comparing two apparently nonnormal distributions?. J Clin Epidemiol 2001; 54: 86-92
13. Kirkwood BR, Sterne JAC. Essential Medical Statistics, 2nd edn. Oxford, UK: Blackwell Publishing, 2003
14. Department of Health. NHS Reference Costs: Financial Year 2011 to 2012. https://www.gov.uk/government/publications/nhs-reference-costs-financialyear-2011-to-2012 (Accessed 21 July 2014
15. Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can't tell us about ESRD. Clin J Am Soc Nephrol 2013; 8: 845-851
16. The UK Renal Registry 8th Annual Report. Bristol, UK, 2005
17. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732-737
18. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 25: 583-592
19. Joss N, Staatz CE, Thomson AH, et al. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007; 21: 136-143